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Abstract
The aim of this study was to examine associations of body composition (fat mass index, % fat mass, fat-free mass index,
body mass index) and physical fitness (cardiorespiratory fitness and handgrip strength) with gestational diabetes and
cardiovascular health in early pregnancy. This cross-sectional study utilized baseline data (n= 303) collected in early
pregnancy from the HealthyMoms trial. Body composition was measured using air-displacement plethysmography,
cardiorespiratory fitness was assessed by means of the 6-min walk test and handgrip strength using a dynamometer.
Logistic regression was used to estimate odds ratios (ORs) for gestational diabetes as well as high (defined as 1 SD
above the mean) blood pressure, homeostatic model assessment for insulin resistance (HOMA-IR), and metabolic
syndrome score (MetS score) per 1 SD increase in body composition and fitness variables. Fat mass index, % fat mass
and body mass index were all strongly associated with gestational diabetes (ORs: 1.72–2.14, P ≤ 0.003), HOMA-IR (ORs:
3.01–3.80, P < 0.001), blood pressure (ORs: 1.81–2.05, P < 0.001) and MetS score (ORs: 3.29–3.71, P < 0.001). Associations
with fat-free mass index were considerably weaker (ORs: 1.26–1.82, P= 0.001–0.15) and were strongly attenuated after
adjustments for fat mass index (ORs: 0.88–1.54, P= 0.039–0.68). Finally, greater cardiorespiratory fitness was associated
with lower risk of high HOMA-IR and MetS score (ORs: 0.57–0.63, P ≤ 0.004) although these associations were
attenuated when accounting for fat mass index (ORs: 1.08-1.11, P ≥ 0.61). In conclusion, accurately measured fat mass
index or % fat mass were strongly associated with gestational diabetes risk and markers of cardiovascular health
although associations were not stronger than the corresponding ones for body mass index. Fat-free mass index had
only weak associations with gestational diabetes and cardiovascular health which support that the focus during
clinical care would be on excess fat mass and not fat-free mass.
Background
Pregnancy induces significant changes to the cardio-
vascular system1 and evidence demonstrates that the
cardiovascular health during pregnancy is predictive of
pregnancy outcomes as well as for long-term health
outcomes postpartum2. For instance, gestational diabetes
or hyperglycemia during pregnancy is associated with
greater risk of adverse pregnancy outcomes such as pre-
eclampsia, cesarean section and perinatal mortality3,4 as
well as the long-term risk of type-2 diabetes5. Similarly,
hypertensive disorders during pregnancy have been linked
to maternal and infant mortality and morbidity6 and
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hypertension later in life7. Studies also suggest that clus-
tering of individual cardiovascular risk factors such as
glycemia, high blood pressure, high triglycerides and low
high-density lipoprotein (HDL) cholesterol, all compo-
nents in the metabolic syndrome (MetS), are more
strongly associated with adverse pregnancy outcomes
than single risk factors8,9. For instance, a recent study
used the health-oriented ideal cardiovascular health fra-
mework by the American Heart Association10 to describe
cardiovascular health and found that a composite score of
five cardiovascular health metrics (glycemia, blood pres-
sure, triglycerides, body mass index [BMI] and smoking)
was associated with wider range of pregnancy outcomes
than the individual metrics9. Altogether, the literature,
e.g.2–5,7, support pregnancy as a unique opportunity to
identify women at risk for future cardiovascular events
and to provide prevention and treatment strategies to
support long-term cardiovascular health2. However,
despite the importance of favorable cardiovascular health
during pregnancy, there are still gaps of knowledge
regarding modifiable risk factors of poor cardiovascular
health during pregnancy which may be of importance for
effective preventive and treatment strategies.
Firstly, although obesity is a strong risk factor for gesta-
tional diabetes and other cardiovascular risk factors such as
gestational hypertension and preeclampsia11, categorization
of obesity is based on BMI which is a relatively poor marker
of body fatness also in pregnancy12. Furthermore, BMI
cannot differentiate between fat mass (FM) and fat-free
mass (FFM), which may have different health effects13. The
few studies that have examined body composition, using
accurate methodology, in relation to cardiovascular health
have generally reported positive associations of FM with
glycemia and insulin resistance14–16. However, little is
known whether the FFM of the body weight is related to
cardiovascular health and the few previous studies have
shown conflicting results15,17. Furthermore, it is not fully
examined whether a state-of-the art body composition
measure would convey cardiovascular health better than
BMI which is widely used but also widely criticized18.
Secondly, cardiorespiratory fitness is considered a
strong marker of health and has been linked to more
favorable cardiovascular health in numerous studies of
non-pregnant populations19,20. Furthermore, adequate
cardiorespiratory fitness has also been found to attenuate
the negative health effects of obesity18,21. However, to the
best of our knowledge, no previous study has examined
associations of physical fitness with cardiovascular health
in pregnant women.
The aim of this study was therefore to examine asso-
ciations of body composition and physical fitness with
cardiovascular health (i.e. glycemia and gestational dia-
betes, insulin resistance, blood pressure and MetS score)
in early pregnancy.
Methods
Study design and participants
The present cross-sectional study utilized data from the
HealthyMoms trial (clinicaltrials.gov; NCT03298555) and
detailed information regarding study design and metho-
dology has been published in the study protocol22. Briefly,
the HealthyMoms trial is a two-arm randomized con-
trolled trial that examines the effectiveness of a smart-
phone app (the HealthyMoms app) for promoting healthy
weight gain (primary outcome), diet and physical activity
during pregnancy. Participants were recruited at routine
visits in the first trimester at maternity clinics in Lin-
köping, Norrköping and Motala, Sweden during October
2017 to March 2020. The inclusion criteria were a sin-
gleton pregnancy, age of 18 years and above and an ability
to read and speak Swedish sufficiently well to understand
the content of the HealthyMoms app and provide written
informed consent. In the present study, we analyzed data
from the baseline measure conducted around gestational
week 14 (13.9 ± 0.7 gestational weeks) before the rando-
mization and access to any intervention content (i.e. the
HealthyMoms app)22. A total of 305 women completed
the baseline measurement that was conducted in the
morning after an overnight fast. During the measurement,
participants provided a fasting blood sample, had their
body composition and physical fitness measured and
completed questionnaires including questions regarding
age, pre-pregnancy weight and physical activity level23,
parity, occupation, and educational attainment. Of the
305 women, two were not able to perform the 6-min walk
test to assess cardiorespiratory fitness (due to pelvic girdle
pain and recent pneumonia) and thus the final analytic
sample included 303 women. The HealthyMoms trial has
received approval from the Regional Ethical Review Board
in Linköping, Sweden (DNR: 2017/112-31 and 2018/262-
32) and all women provided a written informed consent
before entering the trial.
Study variables
Body composition
Body height was measured by means of a wall-
stadiometer (Tillquist, Spånga, Sweden). Body composi-
tion and weight were measured using the Bod Pod which
utilize air-displacement plethysmography as previously
described24. Briefly, air-displacement plethysmography
measures body volume and together with an accurate
measure of body weight, the body density can be calcu-
lated. By using appropriate densities for FM and FFM,
body composition can then be calculated using the so-
called two component model (i.e. dividing the body into
FM and FFM)25,26. The use of air-displacement plethys-
mography can also provide accurate estimates of body
composition in pregnancy if the increase in hydration of
the FFM (and consequently lower FFM density) is
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accounted for25,26. Therefore, we utilized densities for FM
(0.900 g/cm3) and FFM (1.098 g/cm3) appropriate for
gestational week 1426 to calculate the % fat mass (% FM).
The FFM-density appropriate for gestational week 14 was
calculated using the equation by Most et al.26 which is
based on data from van Raij27. BMI was calculated as
weight (kg) divided by height squared (m2). Fat mass
index (FMI) and fat-free mass index (FFMI) were calcu-
lated as FM (kg) or FFM (kg) divided by height squared
(m2), respectively.
Physical fitness
Cardiorespiratory fitness was measured using the 6-
min-walk test. In this test, women were instructed to
walk as far as possible (back and forth in a 30-m cor-
ridor) over a period of 6 min22,28. The distance covered
(in m) was used as a measure of cardiorespiratory fit-
ness. Average heart rate during the 6-min walk test was
assessed (Polar M400, Polar Electro Oy, Kempele, Fin-
land) as a measure of exertion. Upper body muscular
strength was measured using the handgrip test. In this
test, participants squeezed an analogue dynamometer
(TKK 5001, Grip-A, Takei, Tokyo, Japan) as hard as
possible for a few seconds22. Prior to the test hand size
was measured to determine grip span and the dynam-
ometer was adjusted accordingly in order to assure
correct setting to acquire maximal handgrip strength29.
The women performed the test two times with each
hand. Subsequently, the best attempt of each hand was
averaged and used in the analysis.
Cardiovascular health
A venous fasting blood sample was taken to analyze
glucose, insulin, cholesterol, triglycerides, low-density
lipoprotein (LDL) and HDL cholesterol. Plasma glucose
was analyzed by means of the glucose hexokinase method
and serum insulin was analyzed using the Elecsys elec-
trochemiluminescence immunoassay on a Cobas 602
(Roche Diagnostics Scandinavia AB, Bromma, Sweden).
Plasma concentrations of total cholesterol, HDL choles-
terol, and triglycerides were measured directly, using the
enzymatic, colorimetric method on a Cobas c 701 module
(Roche Diagnostics Scandinavia AB, Bromma, Sweden),
while LDL cholesterol was calculated by the Friedewald
equation30. All analyzes were performed at the Depart-
ment of Clinical Chemistry, Linköping University, Lin-
köping, Sweden, which is accredited for these analyses
(ISO/IEC 17025).
Gestational diabetes was defined as fasting plasma glu-
cose ≥ 5.1 mmol/l according to the International Asso-
ciation of Diabetes and Pregnancy Study Groups
Recommendation31. Homeostatic model assessment for
insulin resistance (HOMA-IR) was calculated using fast-
ing glucose and insulin values (fasting insulin [µU/L] ×
fasting glucose [mmol/L])/22.5)32. Due to its skewness,
HOMA-IR was transformed with the natural logarithm
(ln) in the statistical analyses. Systolic and diastolic blood
pressure were measured using an electric sphygmoman-
ometer (ProBP 3400 series, WelchAllyn, NY, USA) after a
five-min rest in an upright resting position. Two mea-
surements of blood pressure were conducted and if either
of the systolic or diastolic blood pressure differed more
than 10 mmHg, a third measurement was performed. The
averages of systolic and diastolic blood pressure, respec-
tively, were used in the analysis. We also calculated a
MetS score using the components in the MetS omitting
waist circumference since body fatness was a main
exposure in the study. Thus, the MetS score was calcu-
lated as the standardized sum of the z scores of trigly-
cerides, inverted HDL cholesterol, glucose and the
average of systolic and diastolic blood pressures as
described previously33. A high MetS score as well as high
HOMA-IR and average of systolic and diastolic blood
pressure were defined as 1 standard deviation (SD) above
the mean or more.
Statistical analysis
As reported elsewhere22, the HealthyMoms trial was
dimensioned to be sufficiently powered for the primary
outcome (i.e. gestational weight gain). For the current
analysis, a sample size of 303 women would provide 80%
power (two-tailed, α= 0.05) to detect a standardized
regression coefficient of 0.16. First, we examined asso-
ciations of body composition and physical fitness with
cardiovascular health variables using linear regression.
Three sets of regression models were fitted: one unad-
justed, one partially adjusted (including age, educational
attainment [university degree vs. no other education] and
parity [0 vs. ≥ 1]) and one adjusted (including covariates in
the partially adjusted model as well as mutual adjustments
for cardiorespiratory fitness, handgrip strength, FMI and
FFMI). The adjusted model with BMI and % FM as
exposures did not include FMI and FFMI (as BMI and %
FM are strongly dependent of FMI and FFMI). Second, we
calculated the odds ratios (ORs) of gestational diabetes
and high HOMA-IR, average of systolic and diastolic
blood pressure and MetS score per 1 SD difference (to
facilitate comparison between exposures) in body com-
position and physical fitness variables by means of binary
logistic regression. Three sets of regression models (i.e.
unadjusted, partially adjusted, and adjusted) were gener-
ated with similar adjustments as described above. We did
not observe any violations against the assumptions of our
regression models34. Statistical analysis was conducted
using SPSS (IMB SPSS statistics, version 26, IBM Corp.,
NY, USA) and two-sided P values < 0.05 (without
adjustments for multiple comparisons) were considered
statistically significant.




Based on participants’ self-reported pre-pregnancy BMI
(23.7 ± 3.9 kg/m2), 2.0% (n= 6) had underweight, 70.0%
(n= 212) had normal weight, 21.5% (n= 65) had over-
weight and 6.6% (n= 20) had obesity before pregnancy.
Table 1 presents the descriptive data of the women
measured around gestational week 14.
Body composition and cardiovascular health
Associations of body composition with cardiovascular
health variables in early pregnancy (both measured
around gestational week 14) examined by linear regres-
sion are presented in Table 2. BMI, FMI and % FM were
all strongly and positively associated with glucose,
HOMA-IR, systolic and diastolic blood pressure and MetS
score (all β ≥ 0.30, all P < 0.001). Noteworthy, associations
with FMI were generally unaffected by the mutual
adjustment for FFMI and physical fitness (i.e. the adjusted
model). Higher FFMI was statistically significantly asso-
ciated with higher glucose, HOMA-IR, systolic and dia-
stolic blood pressure and MetS score in the unadjusted
and partially adjusted model (all β ≥ 0.12, all P ≤ 0.040),
although associations were weaker than the correspond-
ing associations for BMI, FMI and % FM. Noteworthy, all
associations between FFMI and the cardiovascular health
variables were considerably weaker and not statistically
significant in the adjusted model (all P ≥ 0.41), i.e. after
adjustments for FMI and physical fitness.
Figure 1 shows the odds ratios of gestational diabetes
and high (defined as 1 SD above the mean) HOMA-IR,
average of systolic and diastolic blood pressure and MetS
score associated with body composition and physical fit-
ness variables (detailed data in Table S1). One SD higher
BMI, FMI, and % FM were all associated with con-
siderably greater ORs for gestational diabetes (ORs:
1.72–2.14, P ≤ 0.003) as well as high HOMA-IR (ORs:
3.01–3.80, P < 0.001), average of systolic and diastolic
blood pressure (1.81–2.05, P < 0.001) and MetS score
(ORs: 3.29–3.71, P < 0.001) in the unadjusted and the
adjusted models (complete data in Table S1). One SD
higher FFMI was associated with higher ORs for gesta-
tional diabetes (OR: 1.82, P= 0.001), high HOMA-IR
(OR: 1.54–1.63, P < 0.006), and MetS score (OR: 1.63, P=
0.004) in the unadjusted and partially adjusted model.
However, estimates were attenuated in the adjusted model
and only remained statistically significant, yet weaker, for
gestational diabetes (OR: 1.54, P= 0.039).
Physical fitness and cardiovascular health
Higher cardiorespiratory fitness had a weak but statis-
tically significant association with lower HOMA-IR, sys-
tolic blood pressure and MetS score in the unadjusted and
partially adjusted model (all β ≥−0.12, all P ≤ 0.033)
(Table 3). However, these associations were completely
attenuated and not statistically significant (all P ≥ 0.31) in
the adjusted model that also accounted for body com-
position (FMI and FFMI) and handgrip strength. Hand-
grip strength was not associated with any of the
cardiovascular health variables (all P ≥ 0.078).
One SD higher cardiorespiratory fitness was associated
with lower odds of high HOMA-IR (OR: 0.60, P= 0.001)
and MetS score (0.57, P= 0.001) in the unadjusted model
as presented in Fig. 1 (detailed data in Table S1). Note-
worthy, these associations became attenuated and not
statistically significant in the adjusted model. Finally,
handgrip strength was not associated with any of the
cardiovascular health variables presented in Fig. 1.
Sensitivity analyses
We conducted several sensitivity analyses to assess the
trustworthiness of our findings. First, we further assessed
whether adjustments for FMI was the sole reason to the
strongly attenuated estimates in the adjusted model for
FFMI and cardiorespiratory fitness. As shown in Table S2,
estimates were strongly attenuated by adjustments for
FMI which indicates that FMI mediates the associations of
FFMI and cardiorespiratory fitness with cardiovascular
health. Second, we examined if further adjustments for
the self-reported physical activity level before pregnancy
had any influence on the estimates. However, results and
conclusions remained similar after this adjustment
(results not shown). Third, we also performed a series of
sensitivity analyses to examine to what extent low exer-
tion and thus lower performance and heart rate during
the test may influence our findings. There was data
regarding average heart rate during the 6-min walk test
for 290 (95.7%) of the women. As shown in Tables S3 and
S4, we re-calculated our regression models only including
women with an average heart rate during the test above
60% or 70% of their estimated maximum heart rate35. We
also performed an analysis in which we included the
average heart rate (expressed as percentage of estimated
maximum) during the 6-min-walk test as a covariate in
the models to explore whether estimates for cardior-
espiratory fitness would be influenced (Tables S3 and S4).
However, in both these sensitivity analyses, associations of
cardiorespiratory fitness with cardiovascular health vari-
ables were quite comparable to our main results and
conclusions were similar, i.e. cardiorespiratory fitness was
associated with more favorable cardiovascular health




This study examined the associations of body compo-
sition and physical fitness with gestational diabetes and
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cardiovascular health. The main finding was that FMI or
% FM measured with state-of-the-art methodology,
despite strong associations, did not convey gestational
diabetes risk or markers of cardiovascular health better
than BMI. Furthermore, although greater FFMI had
associations with greater odds of gestational diabetes as
well high HOMA-IR and MetS score, associations were
strongly attenuated by adjustments for FMI. Another
main finding was that performance in the 6-min-walk test
was associated with lower odds for gestational diabetes,
and high HOMA-IR and MetS score corroborating car-
diorespiratory fitness as a marker of health. However,
associations with performance in the 6-min-walk test
were diminished after adjustments for FMI.
Comparison with previous studies
We observed strong associations between body fatness
variables (FMI and % FM) and cardiovascular health
variables which is in line with previous literature that
have reported relationships of FMI and % FM with gly-
cemia15 and insulin resistance14–16 in pregnancy. We also
expand the literature by providing data regarding the
associations of accurately measured body composition in
relation to blood pressure and components of the MetS
in pregnancy.
Regarding the FFM, the few previous studies in relation
to pregnancy have shown somewhat conflicting results
and have been conducted in different stages around
pregnancy. For instance, Diaz et al.17 reported that pre-
pregnancy FFMI was at least as strong predictor of
HOMA-IR in pregnancy as FMI was. This is in contrast to
our previous findings that showed that FMI in gestational
week 32 appeared to be more strongly correlated with
HOMA-IR than FFMI (r2= 0.32 vs. 0.14)15. This latter
finding agree relatively well with our results showing that
although greater FFMI was associated with higher glyce-
mia, HOMA-IR, blood pressure, and MetS score, asso-
ciations become attenuated in the adjusted model and
were markedly weaker than for the corresponding asso-
ciations with FMI in all regression models. Our findings
were also clear that a potential benefit from a high FFM
on cardiovascular health was evidently lacking which is in
line with a review of previous studies36. Nevertheless, it is
also relevant to consider that the relatively small variation
in FFMI as compared to FMI could have contributed to
the generally weak association observed.
BMI was generally as strongly associated to gestational
diabetes and cardiovascular health variables as FMI and %
FM, which aligns well with the fact that FFMI did not
have any favorable associations with cardiovascular
health. These results can also be reconciled with previous
studies that have found BMI to convey cardiovascular
disease risk well despite not being a very accurate proxy of
body fatness18,37,38.
To the best of our knowledge, no previous study has
examined the relation of physical fitness to gestational
diabetes and cardiovascular health in pregnancy. Our
novel findings show that cardiorespiratory fitness is
associated with lower HOMA-IR and MetS score which
show the role of cardiorespiratory fitness as a marker of
health also in pregnant women. However, the associations
were diminished in the adjusted model showing that
cardiorespiratory fitness was not an independent pre-
dictor of cardiovascular health. The lack of associations in
the adjusted model could be attributed to the fact that our
sample was pregnant women, that the women had




Age (y) 31.3 ± 4.1 20–44
Educational attainment
Primary school (9 y) 0.7% (2)
High school (12 y) 21.5% (65)




Weight (kg) 67.6 ± 11.6 44.7–120.0
Height (m) 1.67 ± 0.06 1.46–1.82
Smoking before pregnancy 2.0% (6)
Body composition
BMI (kg/m2) 24.2 ± 3.8 17.4–41.1
FMI (kg/m2) 7.9 ± 3.2 3.6–22.7
FM (%) 31.8 ± 7.3 17.2–55.3
FFMI (kg/m2) 16.3 ± 1.3 12.8–20.0
Physical fitness
6-min walk test (m) 671 ± 55 497–803
Handgrip strength test (kg) 33.2 ± 5.1 13.8–49.8
Cardiovascular health variables
Glucoseb,c (mmol/l) 4.8 ± 0.3 3.3–5.8
Insulind (mIU/l) 6.4 ± 3.0 1.7–19.0
HOMA-IRb 1.4 ± 0.7 0.4–4.5
Systolic blood pressure (mmHg) 108 ± 8 91–140
Diastolic blood pressure (mmHg) 70 ± 6 54–96
Total cholesterolc (mmol/l) 4.6 ± 0.7 3.1–6.9
Triglyceridesc (mmol/l) 1.0 ± 0.4 0.4–3.0
HDL cholesterolc (mmol/l) 2.0 ± 0.3 1.1–3.0
Gestational diabetesb 12.3% (37)
HOMA-IR above 1 SD of meane 17.2% (52)
Blood pressure above 1 SD of meane 14.9% (45)
MetS-score above 1 SD of mean 14.6% (44)
BMI body mass index, FM fat mass, FMI fat mass index, FFMI fat-free mass index,
HOMA-IR homeostatic model assessment-insulin resistance, MetS Score Meta-
bolic Syndrome score, SD standard deviation.




eCut-offs for 1 SD above the mean; HOMA-IR: ≥ 2.00; Average of systolic and
diastolic blood pressure: 96.25 mmHg.
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relatively good cardiovascular health, the choice of fitness
test or that FM may mediate at least some of the asso-
ciation between fitness and cardiovascular risk factors39.
Clearly, further studies are needed to elucidate the role of
cardiorespiratory fitness for the development of gesta-
tional diabetes as well as its implications on cardiovas-
cular health in pregnant women.
Strengths and limitations
The major strength of the study was the relatively large
sample of pregnant women that was measured using
accurate body composition methodology using FFM
density values appropriate for gestational week 1425,26.
Furthermore, the comprehensive measurement of the
women enabled analyses that were mutually adjusted for
body composition and physical fitness.
The study also has several limitations to be acknowl-
edged. Although this is, to the best of our knowledge, the
first study to examine associations of physical fitness with
gestational diabetes and cardiovascular health in pregnant
women, we utilized a sub-maximal measure of cardior-
espiratory fitness. The distance covered and the heart rate
during the 6-min-walk-test was somewhat higher than in
comparable studies40,41 which indicate that the women in
general did perform well in the test. Nevertheless, we
cannot exclude the fact that participants with too low
exertion in the 6-min-walk-test may have influenced our
results. Although our sensitivity analyses corroborated
our findings (Table S3 and S4), future studies should
consider more accurate measures of cardiorespiratory
fitness. Furthermore, our sample consisted to a large
extent of women with high educational attainment which
somewhat limits generalizability. However, we observed a
wide range in the physical fitness and body composition
variables and had representation across all BMI-categories
although the proportion of women with overweight and
Table 2 Associations of body composition with cardiovascular health in early pregnancy examined by linear regression.
Cardiovascular health variables Body composition variables Unadjusted Partially Adjusteda Adjustedb
β P β P β P
Glucose BMI 0.39 <0.001 0.38 <0.001 0.41 <0.001
FMI 0.40 <0.001 0.39 <0.001 0.40 <0.001
% FM 0.36 <0.001 0.36 <0.001 0.38 <0.001
FFMI 0.18 0.002 0.17 0.003 0.05 0.45
HOMA-IR BMI 0.55 <0.001 0.56 <0.001 0.57 <0.001
FMI 0.58 <0.001 0.58 <0.001 0.61 <0.001
% FM 0.58 <0.001 0.57 <0.001 0.59 <0.001
FFMI 0.18 0.001 0.21 <0.001 −0.01 0.87
Systolic blood pressure BMI 0.34 <0.001 0.34 <0.001 0.33 <0.001
FMI 0.35 <0.001 0.35 <0.001 0.33 <0.001
% FM 0.31 <0.001 0.31 <0.001 0.30 <0.001
FFMI 0.15 0.009 0.16 0.006 0.03 0.68
Diastolic blood pressure BMI 0.33 <0.001 0.34 <0.001 0.33 <0.001
FMI 0.35 <0.001 0.36 <0.001 0.37 <0.001
% FM 0.34 <0.001 0.34 <0.001 0.34 <0.001
FFMI 0.12 0.040 0.13 0.029 −0.02 0.70
MetS score BMI 0.50 <0.001 0.50 <0.001 0.51 <0.001
FMI 0.52 <0.001 0.51 <0.001 0.51 <0.001
% FM 0.48 <0.001 0.47 <0.001 0.47 <0.001
FFMI 0.21 <0.001 0.21 <0.001 0.05 0.41
β, standardized regression coefficient, BMI body mass index; FM fat mass, FMI fat mass index, FFMI fat-free mass index, HOMA-IR homeostatic model assessment-
insulin resistance, MetS score Metabolic Syndrome score.
aModel included age, educational attainment, and parity.
bModel included age, educational attainment, and parity as well as cardiorespiratory fitness and handgrip strength. For FMI and FFMI, the models were mutually
adjusted for FMI and FFMI.
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Fig. 1 Body composition, physical fitness and cardiovascular health in early pregnancy. Odds ratios of gestational diabetes and high (defined
as above 1 SD above the mean) HOMA-IR, average of systolic and diastolic blood pressure and MetS score per 1 SD difference in body composition
and physical fitness variables measured in early pregnancy. Binary logistic regression was used to estimates odds ratios with 95% confidence intervals.
Adjusted model included age, educational attainment and parity as well as cardiorespiratory fitness, handgrip strength, FMI, and FFMI (models with
BMI and % FM did not include FMI and FFMI). BMI body mass index, CRF cardiorespiratory fitness, FM fat mass, FMI fat mass index, FFMI fat-free mass
index, HGS handgrip strength, HOMA-IR homeostatic model assessment-insulin resistance, MetS score Metabolic Syndrome score.
Table 3 Associations of physical fitness with cardiovascular health in early pregnancy examined by linear regression.
Cardiovascular health variables Physical fitness variables Unadjusted Partially Adjusteda Adjustedb
β P β P β P
Glucose Cardiorespiratory fitness −0.09 0.13 −0.09 0.13 0.08 0.20
Handgrip strength 0.06 0.33 0.04 0.55 −0.02 0.80
HOMA-IR Cardiorespiratory fitness −0.20 0.001 −0.17 0.002 0.05 0.31
Handgrip strength 0.07 0.21 0.09 0.12 0.06 0.28
Systolic blood pressure Cardiorespiratory fitness −0.13 0.024 −0.12 0.033 −0.01 0.92
Handgrip strength 0.09 0.13 0.10 0.11 0.07 0.24
Diastolic blood pressure Cardiorespiratory fitness −0.11 0.051 −0.11 0.062 0.02 0.81
Handgrip strength 0.09 0.13 0.11 0.078 0.09 0.13
MetS score Cardiorespiratory fitness −0.19 0.001 −0.18 0.002 0.03 0.65
Handgrip strength 0.04 0.48 0.02 0.72 −0.02 0.70
β standardized regression coefficient, HOMA-IR homeostatic model assessment-insulin resistance, MetS score Metabolic Syndrome score.
aModel included age, educational attainment and parity.
bModel included age, educational attainment, parity, FMI and FFMI as well as mutual adjustment for cardiorespiratory fitness and handgrip strength.
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obesity was somewhat lower compared to the general
pregnant population in Sweden42. Furthermore, we
adjusted our estimates for educational attainment in the
partially adjusted model with minimal influence on our
estimates. Finally, in lieu of well-established criteria
applicable during pregnancy we classified individuals that
were 1 SD above the mean to have high HOMA-IR, blood
pressure, and MetS score which also represent a limita-
tion. Finally, the fact that we cannot differentiate the body
composition of the fetus from that of its mother may be
considered as a limitation. Nevertheless, the contribution
of FFM and FM from the fetus may be considered insig-
nificant considering that an average fetus in gestational
week 14 weighs ~100 grams (virtually only FFM)43,44
while the average FFM of the maternal body is ~45 kg.
Furthermore, we accounted for the pregnancy-induced
changes in the FFM hydration by using a FFM-density
appropriate for gestational week 1426.
Clinical and public health relevance
Our study provides some findings of relevance for
clinical care and public health. First, BMI conveys gesta-
tional diabetes risk and cardiovascular health as good as a
state-of-the-art body composition measure. This is of
importance since BMI is easily measured within clinical
care and our results do not motivate that additional, often
costly and time-consuming, body composition measures
for the identification of women with an increased risk of
gestational diabetes and cardiovascular disease should be
introduced. Furthermore, the contribution of FFM to
gestational diabetes and cardiovascular health appears
negligible when compared to the observed importance of
FM. Thus, our findings support that the focus during
clinical care would be on excess FM and not on levels
of FFM.
Conclusions
FMI or % FM measured with state-of-the-art metho-
dology were strongly associated with gestational diabetes
risk and markers of cardiovascular health although asso-
ciations were not stronger than the corresponding ones
for BMI. Finally, greater cardiorespiratory fitness was
associated with lower risk of high HOMA-IR and MetS
score although these associations were attenuated when
accounting for FMI.
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